Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zeam
    Member
    • Oct 2010
    • 43

    #1

    Is BQSR necessary for de novo mutation calling?

    Hi there,
    I have been using GATK to identify variants recently. I saw that BQSR is highly recommended. But I don’t whether it is still needed for de novo mutation calling. For example, I want to identify de novo mutations generated in the progenies by single seed descent methods in plants. For example, in the paper of “The rate and molecular spectrum of spontaneous mutations in Arabidopsis thaliana”, these spontaneous arising mutations may not included in the known sites of variants. Based on documentation posted in GATK websites, they assume that all reference mismatches we see are therefore errors and indicative of poor base quality. Under this assumption, these de novo mutations may be missed in the step of variant calling. So in this situation, what should I do? Or should I skip the BQSR step?
    Also what should I do when I reach to step- VQSR?
    Hope some GATK developers can help me on this.
    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...